SMTL ID : 3km4.1

Optimization of Orally Bioavailable Alkyl Amine Renin Inhibitors

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

homo-dimer

Ligands

1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 3 residues within 4Å: Chain A: H.71, N.72, T.74 No protein-ligand interaction detected (PLIP)

4 x 22X: (3R)-3-[(1S)-4-(acetylamino)-1-(3-chlorophenyl)-1-hydroxybutyl]-N-{(1S)-2-cyclohexyl-1-[(methylamino)methyl]ethyl}piperidine-1-carboxamide(Non-covalent)

22X.2: 22 residues within 4Å: Chain A: T.15, Q.16, Y.17, V.33, D.35, G.37, Y.80, T.82, P.115, F.116, L.118, A.119, F.121, V.124, D.223, T.224, G.225, A.226, S.227, M.300 Chain B: L.249 Ligands: 22X.3 18 PLIP interactions: 17 interactions with chain A, 1 interactions with chain B Hydrophobic interactions: A:Y.17, A:Y.80, A:T.82, A:F.116, A:L.118, A:A.119, A:F.121, A:F.121, A:V.124, B:L.249 Hydrogen bonds: A:Y.17, A:D.223, A:G.225, A:G.225, A:S.227 Water bridges: A:T.82, A:D.223 pi-Stacking: A:F.121 22X.3: 15 residues within 4Å: Chain A: M.13, T.15, L.118, A.226, S.227, Y.228, F.250, D.251, F.283, T.294, H.298, M.300 Chain B: L.114, F.250 Ligands: 22X.2 9 PLIP interactions: 7 interactions with chain A, 2 interactions with chain B Hydrophobic interactions: A:L.118, A:Y.228, A:F.250, A:D.251, A:T.294, B:L.114, B:F.250 Hydrogen bonds: A:H.298 Water bridges: A:S.230 22X.5: 24 residues within 4Å: Chain A: L.249 Chain B: T.15, Q.16, Y.17, V.33, D.35, G.37, Y.80, S.81, T.82, P.115, F.116, L.118, A.119, F.121, V.124, Y.159, D.223, T.224, G.225, A.226, S.227, M.300 Ligands: 22X.6 20 PLIP interactions: 19 interactions with chain B, 1 interactions with chain A Hydrophobic interactions: B:Q.16, B:Y.17, B:Y.80, B:Y.80, B:T.82, B:F.116, B:L.118, B:A.119, B:F.121, B:F.121, B:V.124, A:L.249 Hydrogen bonds: B:Y.17, B:S.81, B:D.223, B:G.225, B:G.225, B:S.227 Water bridges: B:T.15, B:T.15 22X.6: 17 residues within 4Å: Chain A: L.114, F.250 Chain B: M.13, T.15, P.115, L.118, A.226, S.227, Y.228, R.248, F.250, D.251, F.283, E.285, T.294, M.300 Ligands: 22X.5 9 PLIP interactions: 6 interactions with chain B, 3 interactions with chain A Hydrophobic interactions: B:Y.228, B:F.250, B:T.294, A:L.114, A:L.114, A:F.250 Hydrogen bonds: B:S.227, B:S.227, B:Y.228

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.4: 3 residues within 4Å: Chain B: N.72, T.74, M.104 1 PLIP interactions: 1 interactions with chain B Water bridges: B:R.136

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Xu, Z. et al., Optimization of orally bioavailable alkyl amine renin inhibitors. Bioorg.Med.Chem.Lett. (2010)

Release Date

2010-01-12

Peptides

Renin: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Renin

Related Entries With Identical Sequence